152 related articles for article (PubMed ID: 32415868)
1. Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent HER4 intracellular domain trafficking.
Lanotte R; Garambois V; Gaborit N; Larbouret C; Musnier A; Martineau P; Pèlegrin A; Chardès T
Cancer Sci; 2020 Jul; 111(7):2508-2525. PubMed ID: 32415868
[TBL] [Abstract][Full Text] [Related]
2. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.
Naresh A; Long W; Vidal GA; Wimley WC; Marrero L; Sartor CI; Tovey S; Cooke TG; Bartlett JM; Jones FE
Cancer Res; 2006 Jun; 66(12):6412-20. PubMed ID: 16778220
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation.
Feng SM; Muraoka-Cook RS; Hunter D; Sandahl MA; Caskey LS; Miyazawa K; Atfi A; Earp HS
Mol Cell Biol; 2009 Feb; 29(3):892-906. PubMed ID: 19047365
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic HER4/4ICD transcriptional activation domains are required for STAT5A activated gene expression.
Han W; Sfondouris ME; Semmes EC; Meyer AM; Jones FE
Gene; 2016 Oct; 592(1):221-226. PubMed ID: 27502417
[TBL] [Abstract][Full Text] [Related]
5. HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer.
Jones FE
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):247-58. PubMed ID: 18473151
[TBL] [Abstract][Full Text] [Related]
6. Direct coupling of the HER4 intracellular domain (4ICD) and STAT5A signaling is required to induce mammary epithelial cell differentiation.
Han W; Sfondouris ME; Jones FE
Biochem Biophys Rep; 2016 Sep; 7():323-327. PubMed ID: 28955922
[TBL] [Abstract][Full Text] [Related]
7. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
[TBL] [Abstract][Full Text] [Related]
8. HER4 selectively coregulates estrogen stimulated genes associated with breast tumor cell proliferation.
Han W; Jones FE
Biochem Biophys Res Commun; 2014 Jan; 443(2):458-63. PubMed ID: 24333426
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1.
Kern JA; Wakita R; Sliwkowski MX
Cancer Gene Ther; 1999; 6(6):537-45. PubMed ID: 10608350
[TBL] [Abstract][Full Text] [Related]
10. Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo.
Nielsen TO; Sorensen S; Dagnæs-Hansen F; Kjems J; Sorensen BS
Br J Cancer; 2013 Jun; 108(11):2291-8. PubMed ID: 23695025
[TBL] [Abstract][Full Text] [Related]
11. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.
Williams CC; Allison JG; Vidal GA; Burow ME; Beckman BS; Marrero L; Jones FE
J Cell Biol; 2004 Nov; 167(3):469-78. PubMed ID: 15534001
[TBL] [Abstract][Full Text] [Related]
12. The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer.
Fujiwara S; Hung M; Yamamoto-Ibusuk CM; Yamamoto Y; Yamamoto S; Tomiguchi M; Takeshita T; Hayashi M; Sueta A; Iwase H
Oncotarget; 2014 Jun; 5(11):3919-30. PubMed ID: 25003574
[TBL] [Abstract][Full Text] [Related]
13. HER4 isoform CYT2 and its ligand NRG1III are expressed at high levels in human colorectal cancer.
Guo Y; Duan Z; Jia Y; Ren C; Lv J; Guo P; Zhao W; Wang B; Zhang S; Li Y; Li Z
Oncol Lett; 2018 May; 15(5):6629-6635. PubMed ID: 29616125
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3.
Le Clorennec C; Bazin H; Dubreuil O; Larbouret C; Ogier C; Lazrek Y; Garambois V; Poul MA; Mondon P; Barret JM; Mathis G; Prost JF; Pèlegrin A; Chardès T
Mol Cancer Ther; 2017 Jul; 16(7):1312-1323. PubMed ID: 28507002
[TBL] [Abstract][Full Text] [Related]
15. Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.
Sartor CI; Zhou H; Kozlowska E; Guttridge K; Kawata E; Caskey L; Harrelson J; Hynes N; Ethier S; Calvo B; Earp HS
Mol Cell Biol; 2001 Jul; 21(13):4265-75. PubMed ID: 11390655
[TBL] [Abstract][Full Text] [Related]
16. The HER4 isoform JM-a/CYT2 relates to improved survival in bladder cancer patients but only if the estrogen receptor α is not expressed.
Munk M; Memon A; Poulsen SS; Borre M; Nexo E; Sorensen BS
Scand J Clin Lab Invest; 2013 Sep; 73(6):503-13. PubMed ID: 24015958
[TBL] [Abstract][Full Text] [Related]
17. "Shedding" light on HER4 signaling in normal and malignant breast tissues.
Brockhoff G
Cell Signal; 2022 Sep; 97():110401. PubMed ID: 35820544
[TBL] [Abstract][Full Text] [Related]
18. Role for tyrosine phosphorylation of SUV39H1 histone methyltransferase in enhanced trimethylation of histone H3K9 via neuregulin-1/ErbB4 nuclear signaling.
Nakajo H; Ishibashi K; Aoyama K; Kubota S; Hasegawa H; Yamaguchi N; Yamaguchi N
Biochem Biophys Res Commun; 2019 Apr; 511(4):765-771. PubMed ID: 30833073
[TBL] [Abstract][Full Text] [Related]
19. Nuclear ErbB4 signaling through H3K9me3 is antagonized by EGFR-activated c-Src.
Ishibashi K; Fukumoto Y; Hasegawa H; Abe K; Kubota S; Aoyama K; Kubota S; Nakayama Y; Yamaguchi N
J Cell Sci; 2013 Jan; 126(Pt 2):625-37. PubMed ID: 23230144
[TBL] [Abstract][Full Text] [Related]
20. The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation.
Feng SM; Sartor CI; Hunter D; Zhou H; Yang X; Caskey LS; Dy R; Muraoka-Cook RS; Earp HS
Mol Endocrinol; 2007 Aug; 21(8):1861-76. PubMed ID: 17505063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
